Logo image of NUVA.DE

NORATIS AG (NUVA.DE) Stock Fundamental Analysis

Europe - FRA:NUVA - DE000A2E4MK4 - Common Stock

0.73 EUR
0 (0%)
Last: 11/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall NUVA gets a fundamental rating of 3 out of 10. We evaluated NUVA against 72 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of NUVA have multiple concerns. While showing a medium growth rate, NUVA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NUVA has reported negative net income.
NUVA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NUVA reported negative net income in multiple years.
In multiple years NUVA reported negative operating cash flow during the last 5 years.
NUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFNUVA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

NUVA has a worse Return On Assets (-6.76%) than 72.22% of its industry peers.
Looking at the Return On Equity, with a value of -46.91%, NUVA is doing worse than 77.78% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.60%, NUVA is in line with its industry, outperforming 43.06% of the companies in the same industry.
NUVA had an Average Return On Invested Capital over the past 3 years of 1.90%. This is in line with the industry average of 3.43%.
Industry RankSector Rank
ROA -6.76%
ROE -46.91%
ROIC 0.6%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
NUVA.DE Yearly ROA, ROE, ROICNUVA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

With a Operating Margin value of 4.96%, NUVA perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
In the last couple of years the Operating Margin of NUVA has declined.
The Gross Margin of NUVA (20.00%) is worse than 62.50% of its industry peers.
In the last couple of years the Gross Margin of NUVA has declined.
Industry RankSector Rank
OM 4.96%
PM (TTM) N/A
GM 20%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
NUVA.DE Yearly Profit, Operating, Gross MarginsNUVA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

NUVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NUVA has more shares outstanding
Compared to 5 years ago, NUVA has more shares outstanding
The debt/assets ratio for NUVA is higher compared to a year ago.
NUVA.DE Yearly Shares OutstandingNUVA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NUVA.DE Yearly Total Debt VS Total AssetsNUVA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

NUVA has an Altman-Z score of 1.24. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.
NUVA has a better Altman-Z score (1.24) than 66.67% of its industry peers.
NUVA has a debt to FCF ratio of 10.14. This is a negative value and a sign of low solvency as NUVA would need 10.14 years to pay back of all of its debts.
NUVA has a better Debt to FCF ratio (10.14) than 76.39% of its industry peers.
NUVA has a Debt/Equity ratio of 5.49. This is a high value indicating a heavy dependency on external financing.
NUVA has a worse Debt to Equity ratio (5.49) than 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.49
Debt/FCF 10.14
Altman-Z 1.24
ROIC/WACC0.17
WACC3.58%
NUVA.DE Yearly LT Debt VS Equity VS FCFNUVA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 14.73 indicates that NUVA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 14.73, NUVA belongs to the best of the industry, outperforming 97.22% of the companies in the same industry.
NUVA has a Quick Ratio of 14.73. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.52, NUVA is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 14.73
Quick Ratio 0.52
NUVA.DE Yearly Current Assets VS Current LiabilitesNUVA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for NUVA have decreased strongly by -71.72% in the last year.
The Revenue has grown by 10.60% in the past year. This is quite good.
NUVA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.61% yearly.
EPS 1Y (TTM)-71.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.39%
Revenue 1Y (TTM)10.6%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%71.55%

3.2 Future

Based on estimates for the next years, NUVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.63% on average per year.
NUVA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.40% yearly.
EPS Next Y79%
EPS Next 2Y41.68%
EPS Next 3Y26.7%
EPS Next 5Y15.63%
Revenue Next Year-24.2%
Revenue Next 2Y8.52%
Revenue Next 3Y10.31%
Revenue Next 5Y9.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUVA.DE Yearly Revenue VS EstimatesNUVA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M
NUVA.DE Yearly EPS VS EstimatesNUVA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 -4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUVA.DE Price Earnings VS Forward Price EarningsNUVA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NUVA indicates a rather cheap valuation: NUVA is cheaper than 98.61% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 0.29
EV/EBITDA 92.64
NUVA.DE Per share dataNUVA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

NUVA's earnings are expected to grow with 26.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.68%
EPS Next 3Y26.7%

0

5. Dividend

5.1 Amount

NUVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NORATIS AG

FRA:NUVA (11/5/2025, 7:00:00 PM)

0.73

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-02 2025-10-02
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap9.91M
Revenue(TTM)66.56M
Net Income(TTM)-28054000
Analysts42.22
Price Target1.79 (145.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-35.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-60.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF 0.29
P/OCF 0.29
P/B 0.17
P/tB 0.17
EV/EBITDA 92.64
EPS(TTM)-3.76
EYN/A
EPS(NY)-0.89
Fwd EYN/A
FCF(TTM)2.56
FCFY350.11%
OCF(TTM)2.56
OCFY350.13%
SpS4.9
BVpS4.41
TBVpS4.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.76%
ROE -46.91%
ROCE 0.85%
ROIC 0.6%
ROICexc 0.61%
ROICexgc 0.61%
OM 4.96%
PM (TTM) N/A
GM 20%
FCFM 52.11%
ROA(3y)-2.47%
ROA(5y)-0.91%
ROE(3y)-16.73%
ROE(5y)-6.94%
ROIC(3y)1.9%
ROIC(5y)2.12%
ROICexc(3y)1.95%
ROICexc(5y)2.2%
ROICexgc(3y)1.95%
ROICexgc(5y)2.2%
ROCE(3y)2.69%
ROCE(5y)3.01%
ROICexgc growth 3Y-26.63%
ROICexgc growth 5Y-23.14%
ROICexc growth 3Y-26.63%
ROICexc growth 5Y-23.14%
OM growth 3Y-20.54%
OM growth 5Y-12.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.05%
GM growth 5Y-6.76%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 5.49
Debt/FCF 10.14
Debt/EBITDA 86.08
Cap/Depr 0.39%
Cap/Sales 0%
Interest Coverage 0.19
Cash Conversion 909.63%
Profit Quality N/A
Current Ratio 14.73
Quick Ratio 0.52
Altman-Z 1.24
F-Score4
WACC3.58%
ROIC/WACC0.17
Cap/Depr(3y)14.01%
Cap/Depr(5y)16.5%
Cap/Sales(3y)0.08%
Cap/Sales(5y)0.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%31.39%
EPS Next Y79%
EPS Next 2Y41.68%
EPS Next 3Y26.7%
EPS Next 5Y15.63%
Revenue 1Y (TTM)10.6%
Revenue growth 3Y-3.3%
Revenue growth 5Y-2.61%
Sales Q2Q%71.55%
Revenue Next Year-24.2%
Revenue Next 2Y8.52%
Revenue Next 3Y10.31%
Revenue Next 5Y9.4%
EBIT growth 1Y-66.19%
EBIT growth 3Y-23.16%
EBIT growth 5Y-14.59%
EBIT Next Year124.3%
EBIT Next 3Y38.46%
EBIT Next 5Y23.46%
FCF growth 1Y51.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.37%
OCF growth 3YN/A
OCF growth 5YN/A

NORATIS AG / NUVA.DE FAQ

What is the fundamental rating for NUVA stock?

ChartMill assigns a fundamental rating of 3 / 10 to NUVA.DE.


What is the valuation status of NORATIS AG (NUVA.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to NORATIS AG (NUVA.DE). This can be considered as Overvalued.


What is the profitability of NUVA stock?

NORATIS AG (NUVA.DE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for NORATIS AG?

The Earnings per Share (EPS) of NORATIS AG (NUVA.DE) is expected to grow by 79% in the next year.


Can you provide the dividend sustainability for NUVA stock?

The dividend rating of NORATIS AG (NUVA.DE) is 0 / 10 and the dividend payout ratio is 0%.